Skip to content
Disclosery

Braslyn Ltd.

Follow

13F filer, CIK 1642355, NEW PROVIDENCE, Bahamas

Braslyn Ltd. reported $7,812,816 across 1 holding for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-25-000061

Period
2024-12-31
Reported value
$7.81M
Holdings
1
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TNGXexited-26,961-$208K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0000895345-25-000061, largest first. % of portfolio is the value over $7,812,816, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INSGINSEEGO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 761,483 shares; 2024Q4: 761,483 shares 761,483$7.81M100%0Timeline

Sold out in Q4 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TNGXTANGO THERAPEUTICS INC26,961$208Kshares

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000895345-25-000061 base2025-02-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0000895345-25-000061 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0000895345-24-000581 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0000895345-24-000352 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0000895345-24-000184 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0000895345-24-000064 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-NT 0000895345-23-000632 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-NT 0000895345-23-000488 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-NT 0001567619-23-006075 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-NT 0001567619-23-002831 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-NT 0000950123-22-012321 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-NT 0000950123-22-009475 Quarter ended 2022-06-302022-08-15acceptance time not in the bulk data set
13F-NT 0000950123-22-006478 Quarter ended 2022-03-312022-05-16acceptance time not in the bulk data set
13F-NT 0000950123-22-002989 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-NT 0000950123-21-015591 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-NT 0000950123-21-011429 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-NT 0000950123-21-007063 Quarter ended 2021-03-312021-05-17acceptance time not in the bulk data set
13F-NT 0000950123-21-002844 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set
13F-NT 0000950123-20-012173 Quarter ended 2020-09-302020-11-16acceptance time not in the bulk data set
13F-NT 0000950123-20-009112 Quarter ended 2020-06-302020-08-14acceptance time not in the bulk data set
13F-NT 0000950123-20-005386 Quarter ended 2020-03-312020-05-15acceptance time not in the bulk data set
13F-NT 0000950123-20-002479 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-NT 0000950123-19-011445 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-NT 0000950123-19-008399 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-NT 0000950123-19-005488 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-NT 0000950123-19-002238 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-NT 0000950123-18-011934 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-NT 0000950123-18-008906 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-NT 0000950123-18-005768 Quarter ended 2018-03-312018-05-15acceptance time not in the bulk data set
13F-NT 0000950123-18-002398 Quarter ended 2017-12-312018-02-14acceptance time not in the bulk data set
13F-NT 0000950123-17-010917 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-NT 0000950123-17-007997 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-NT 0000950123-17-005318 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-NT 0000950123-17-002502 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-NT 0000950123-16-022427 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-NT 0000950123-16-020188 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-NT 0000950123-16-017632 Quarter ended 2016-03-312016-05-16acceptance time not in the bulk data set
13F-NT 0000950123-16-015088 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set